NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice GuidelinesGeorge D. Demetri, John Zalcberg, Robert S. Benjamin et al.|Journal of the National Comprehensive Cancer Network|2007Cited by 636
Imatinib for Melanomas Harboring Mutationally Activated or Amplified <i>KIT</i> Arising on Mucosal, Acral, and Chronically Sun-Damaged SkinF. Stephen Hodi, David E. Fisher, Carol Beadling et al.|Journal of Clinical Oncology|2013Cited by 594
Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro.Laurence I. Delmon-Moingeon, Alan G. Jones, David Piwnica‐Worms et al.|PubMed|1990Cited by 252
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal TumorMichael C. Heinrich, Jonathan A. Fletcher, Christopher L. Corless et al.|Journal of Clinical Oncology|2023Cited by 145
Positron emission tomography with <sup>18</sup>F‐fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancerAndrea M. McCollum, Annick D. Van den Abbeele, Steven Burrell et al.|Head & Neck|2004Cited by 94